Dr Harsh Vardhan – Union Health Minister:
For those spreading rumours let it be known that EUA for COVAXIN is differently conditional – in clinical trial mode
EUA for COVAXIN is different from COVISHIELD because its use will be in clinical trial mode.
All COVAXIN recipients to be tracked, monitored as if they’re in trial
COVAXIN approval is ‘Monitored Approval’ with strict follow-up & rolling review
This approval ensures India has an additional vaccine shield in its arsenal especially against potential mutant strains in a dynamic pandemic situation – A strategic decision for our vaccine security